Why Dr. Sperling Trusts OnQ™ Prostate in His Clinical Workflow
Why Dr. Sperling Trusts OnQ™ Prostate in His Clinical Workflow
Want to see more?
< 1 mins
10/13/2026
NeuroQuant PET Is Now FDA Cleared
NeuroQuant PET is now FDA cleared, with centiloid estimation for amyloid PET and support for all FDA-approved dementia tracers.
< 1 mins
10/13/2026
Know Where Your Patient Started: Centiloids in the Era of Anti-Amyloid Therapy
Neuroradiologist Dr. Suzie Bash explains why baseline centiloid values from amyloid PET are key to anti-amyloid maintenance dosing decisions.
< 1 mins
10/01/2026
Comprehensive Insights on Metastatic Melanoma with NeuroQuant® CT | Dr. Niky Farid
By bringing key imaging findings together into a single structured report, NeuroQuant CT helps radiologists and clinicians quickly review critical information.
< 1 mins
10/01/2026
Transforming Prostate Cancer Care with OnQ™ Prostate
OnQ Prostate adds color-coded imaging insights that help clinicians more clearly visualize regions.
< 1 mins
10/01/2026
Why OnQ Prostate Is Different from Other Prostate Imaging Technologies
Learn how OnQ Prostate differs from other prostate imaging technologies and how its advanced diffusion modeling can provide clearer visualization.
< 1 mins
10/01/2026
Why Urologists Choose OnQ™ Prostate for Better Lesion Detection
OnQ Prostate is helping clinicians gain deeper insights from prostate MRI using advanced diffusion modeling.
